Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Execution Drug Utilized in Missouri

By Pharmaceutical Processing | November 9, 2015

Eighteen convicted killers have been executed in Missouri in the last two years, a pace that is expected to slow significantly with death sentences on the decline and many of the 28 remaining death row inmates still filing appeals.

Only Texas, with 24, has performed more executions than Missouri since November 2013.

Executions across the U.S. were largely on hold for many years due to a de facto moratorium as the Supreme Court grappled with the constitutionality of lethal injection. Once that cleared, execution drugs became hard to obtain because major companies refused to sell drugs for lethal use.

Missouri eventually turned to pentobarbital, obtained from a source the state won’t disclose, in late 2013. By then, there was a backlog of inmates whose appeals were exhausted. Attorney General Chris Koster asked the state Supreme Court to set execution dates for many of them, and the court obliged, scheduling one a month since November 2013 (some were halted by court action or clemency).

At the same time, death sentences have been on the decline for many years. Nationally, the 72 death sentences issued last year were the fewest since 1976, according to Amnesty International. None were issued in Missouri.

Death penalty expert Deborah Denno, who teaches at Fordham Law School, cited several factors, including concern over the availability of lethal drugs and worries about executing the innocent.

Medical conditions have cast doubt in two cases this year alone. Ernest Lee Johnson was scheduled to die last week for killing three convenience store workers in 1994, but the U.S. Supreme Court sent the case back to an appeals court for review because his attorneys argued that the execution drug could cause violent seizures due to a benign brain tumor.

And in May, Russell Bucklew, convicted of killing a southeast Missouri man during a 1996 crime spree, was granted a stay over concerns that the execution drug could cause suffering due to his a congenital condition that includes weakened and malformed blood vessels and nose and throat tumors.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE